We are live on ! Find out more
ACM

Aisling Capital Management Portfolio holdings

AUM $476M
1-Year Est. Return 128.63%
This Fund
S&P 500
This Quarter Est. Return
-23.04%
1 Year Est. Return
+128.63%
3 Year Est. Return
+700.94%
5 Year Est. Return
+846.44%
10 Year Est. Return
–
AUM
$94.9M
AUM Growth
–
Cap. Flow
+$116M
Cap. Flow %
122.11%
Top 10 Hldgs %
96.07%
Holding
12
New
12
Increased
–
Reduced
–
Closed
–

Top Buys

Rank Stock Value
1
OBSV
ObsEva SA Ordinary Shares
OBSV
+$20.6M
2
TECX
Tectonic Therapeutic
TECX
+$18.7M
3
MRKR icon
Marker Therapeutics
MRKR
+$14.6M
4
EIDX
Eidos Therapeutics, Inc. Common Stock
EIDX
+$14.2M
5
BHVN
Biohaven Pharmaceutical Holding Company Ltd.
BHVN
+$9.9M

Top Sells

No sells this quarter

Sector Composition

Rank Sector Weight
1 Healthcare 100%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
OBSV
1
DELISTED
ObsEva SA Ordinary Shares
OBSV
$17.6M 18.49%
+1,386,338
New +$20.6M
EIDX
2
DELISTED
Eidos Therapeutics, Inc. Common Stock
EIDX
$15.5M 16.29%
+1,123,630
New +$14.2M
TECX
3
Tectonic Therapeutic
TECX
$529M
$12.3M 12.93%
+61,417
New +$18.7M
MRKR icon
4
Marker Therapeutics
MRKR
$18.8M
$11.1M 11.69%
+200,000
New +$14.6M
BHVN
5
DELISTED
Biohaven Pharmaceutical Holding Company Ltd.
BHVN
$10.2M 10.69%
+274,513
New +$9.9M
SYRE icon
6
Spyre Therapeutics
SYRE
$8.54B
$6.51M 6.85%
+34,745
New +$7.37M
RCUS icon
7
Arcus Biosciences
RCUS
$3.55B
$5.78M 6.09%
+536,513
New +$6.26M
ACRS icon
8
Aclaris Therapeutics
ACRS
$726M
$4.69M 4.94%
+634,455
New +$6.54M
VRNA
9
DELISTED
Verona Pharma
VRNA
$4.28M 4.51%
+443,596
New +$5.04M
ZSAN
10
DELISTED
Zosano Pharma Corporation
ZSAN
$3.39M 3.57%
+45,714
New +$5.79M
NBRV
11
DELISTED
Nabriva Therapeutics plc Ordinary Shares Ireland
NBRV
$2.64M 2.78%
+7,237
New +$3.89M
VIRX
12
DELISTED
Viracta Therapeutics, Inc. Common Stock
VIRX
$1.09M 1.15%
+74,286
New +$3.03M

Similar funds

BF
Brooklyn FI New York $476M AUM 17.97% 1-Year Est. Return
VIA
Vickerman Investment Advisors Spokane, Washington $476M AUM 12.21% 1-Year Est. Return
DE
Devon Energy Houston, Texas $476M AUM
FAM
Frontier Asset Management Sheridan, Wyoming $477M AUM 19.41% 1-Year Est. Return
BHWA
Beacon Harbor Wealth Advisors Virginia Beach, Virginia $477M AUM 49.25% 1-Year Est. Return
AL4A
Accel Leaders 4 Associates Palo Alto, California $475M AUM 391.52% 1-Year Est. Return
LEFP
Leading Edge Financial Planning Knoxville, Tennessee $475M AUM 15.22% 1-Year Est. Return
MVP
Medina Value Partners Los Angeles, California $477M AUM 25.52% 1-Year Est. Return

Aisling Capital Management's Q4 2018 Portfolio in Review

Q4 2018 is the first quarter with a 13F filing on record for Aisling Capital Management, which disclosed 12 positions worth $94.9M. Its ten largest holdings account for 96% of the portfolio.

Its largest position is ObsEva SA Ordinary Shares: 1,386,338 shares worth $17.6M.

By sector, the portfolio is most concentrated in Healthcare at 100% of assets.

  • Aisling Capital Management's largest Q4 2018 buy was ObsEva SA Ordinary Shares: 1,386,338 shares worth $17.6M.
  • Aisling Capital Management's ten largest holdings make up 96% of its $94.9M portfolio in Q4 2018.
  • Aisling Capital Management disclosed 12 positions in Q4 2018, its first 13F filing on record.

Based on Aisling Capital Management's 13F filing for Q4 2018, filed 8 Feb 2019.